FULC R&D Expenses

Fulcrum Therapeutics Inc · R&D Expenses

FULC logo

FULC R&D Expenses

Latest reported$56.24M
FULC TTM R&D Expenses ($25.18M → $56.24M)
High-resolution chart · PNG

FULC r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fulcrum Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
56,240,000
56,783,000
56,103,000
52,031,000
52,374,000
56,648,000
62,538,000
70,193,000
73,792,000
74,380,000
71,801,000
71,368,000
68,496,000
75,666,000
76,782,000
77,128,000
78,839,000
71,198,000
69,701,000
66,934,000
65,497,000
60,894,000
59,042,000
54,465,000
52,321,000
50,406,000
70,553,000
65,845,000
59,312,000
54,240,000
25,184,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.